Austria Beta Blocking Medicine Sales is set to reach $24.67 Million by 2026 from $37.29 Million, will decrease by 5% per year. Since 2017, the market increased 2.4% year on year attaining $2,480 Million. Italy, Canada and Australia respectively came in numbers 2, 3 and 4 in this ranking.